Natural Compounds in Pediatric Disease Treatment
Dmitry O Ivanov1, Roman O Shaikenov2, Svetlana N Morozkina2,3,4,5
1Department of Neonatology, Department of Pathology, Saint Petersburg State Pediatric Medical University, Litovskaya Str., 2, 194110 Saint Petersburg, Russia.
None:
The review evaluates current clinical and epidemiological evidence regarding the use of plant-derived compounds in pediatric practice. Data from randomized controlled trials indicate symptomatic efficacy of selected agents-particularly in acute respiratory infections-alongside generally favorable safety profiles when standardized preparations are used. Emerging research also explores applications in neurodevelopmental disorders, gastrointestinal conditions, and dermatology, and as supportive therapy in pediatric oncology. However, variability in product quality, limited pediatric-specific trials, potential toxicity, and regulatory inconsistencies remain significant challenges. The integration of phytotherapy into pediatric care therefore requires rigorous study design, careful safety monitoring, and clear quality standards to ensure an evidence-based risk-benefit balance.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Drug Dosing: Infants and Children
Pharmaceutical Poisoning: Treatment Strategies
